Work

Novel Agents for Multiple Myeloma to Overcome Resistance in Phase III Clinical Trials

Year: 2013

Type: review

Source: Seminars in Oncology

DOI: 10.1053/j.seminoncol.2013.07.007

Author: Robert Z. Orlowski

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: University of Texas MD Anderson Cancer Center, National Cancer Institute

Awards: M. D. Anderson Cancer Center SPORE in Multiple Myeloma, Southwest Oncology Group Treatment Grant, Cancer Center Support Grant

OpenAlex ID: W2008313359

FWCI: 1.113

Cites: 168

Cited by: 39

Related to: 10